Skip to main content

Equillium, Inc.

EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746466

No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Equillium, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of EQ: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3031+1
Shares12.9M12.2M−687.4K (−5.3%)
Value$28.4M$13.3M−$15.1M (−53.2%)

New holders (7)

Institutions that held Equillium, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to EQ in Q4 2022
InstitutionSharesValue% of portfolio
Callan Capital, LLC103,688$109.9K0.01%
Citadel Advisors LLC50,996$56.1K0.00%
Susquehanna International Group, LLP33,338$36.7K0.00%
Capital CS Group, LLC24,000$25.4K0.03%
Two Sigma Investments, LP14,464$15.3K0.00%
Group One Trading, L.P.200$2200.00%
Bank of America Corp22$230.00%

Sold out (6)

Institutions that held Equillium, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of EQ in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Tang Capital Management LLC600,000$1.33M
United Capital Financial Advisers, LLC13,500$30.0K
Simplex Trading, LLC7,484$16.0K
Kistler-Tiffany Companies, LLC2,000$4.00K
CWM, LLC300$1.00K
Royal Bank of Canada111$0